NCT04844749 2024-02-05
VERACITY
Veru Inc.
Phase 3 Terminated
Clinical Trials
4 trialsNCT03752099 2023-09-26
To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate Cancer
Veru Inc.
Phase 1/2 Terminated
NCT05079360 2023-03-24
Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer
Veru Inc.
Phase 2 Withdrawn
NCT05008510 2022-02-08
VERU-111
Veru Inc.
Phase 2 Withdrawn